TruAlt Bioenergy Q1 FY27: net profit up 1110% to ₹57.15 crore, revenue up 106%
TruAlt Bioenergy (TRUALT) said it has published its Q1 FY27 results (consolidated), reporting revenue of ₹627 crore (+106.3% year on year), net profit of ₹57.15 crore (+1109.6%), earnings per share of ₹6.67. The company is valued at about ₹3,611 crore.
What happened
TruAlt Bioenergy (TRUALT) told the exchanges on 23 October 2026 at 08:03 PM that it has published its Q1 FY27 results (consolidated), reporting revenue of ₹627 crore (+106.3% year on year), net profit of ₹57.15 crore (+1109.6%), earnings per share of ₹6.67.
From the filing: "Outcome of Board Meeting for approval of Unaudited Financial Results(Standalone and Consolidated) along with Limited Review Report thereon, for the Quarter and Half Year ended on September 30, 2026."
Company snapshot
TruAlt Bioenergy is a small-cap company, with a market value of about ₹3,611 crore.
The stock last traded at ₹421.1, against a 52-week range of ₹310.2–₹542 (22.3% below the high).
Before this filing the shares had moved −0.1% over the month and −2.2% over three months. Average daily turnover over the last 20 sessions was about ₹12.75 crore.
Promoters held 70.55% at the end of Q1 FY27; 36.85% of promoter shares were pledged. Foreign institutions owned 0.58% and domestic institutions 8.36%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 304 | 4.7 | 0.67 |
| Q2 FY26 | 115 | -37.9 | -5.37 |
| Q3 FY26 | 713 | 69.3 | 8.07 |
| Q4 FY26 | 596 | 59.9 | 6.99 |
| Q1 FY27 | 627 | 57.2 | 6.67 |
What history shows
BCEIE's records show 2 previous results filings from the company since May 2026.
After those filings, the stock gained 2.0% on average the next trading day and was up 5.0% on average after five days (2 filings with price data).
Market-wide, 9,733 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 28 Jul 2026 | Board Meeting Outcome for Financial Results (Standalone And… | +4.0% | +10.1% |
| 23 Jun 2026 | 'Resubmission of Audited Financial Results for the quarter and year… | +0.1% | −0.1% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 23 October 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
- TruAlt Bioenergy to host Q2FY27 earnings call on Oct 26
- TruAlt Bioenergy Limited (TRUALT.BO) Stock Price, News, Quote & History
- TruAlt Bioenergy Q2 FY27 Earnings Call: Key Details
- TruAlt Bioenergy TRUALT Postal Ballot Independent Director 2026
- TruAlt’s Next Big Upswing May Not Come From Ethanol; It Could Come From the Skies
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.